• #1081079
  • Glaxo Smith Kline #58160082311

Shingrix® Shingles Vaccine 50 Years of Age and Older Zoster Vaccine Recombinant, Adjuvanted 50 mcg / 0.5 mL Injection Single Dose Vial Kit 10 Doses

SHINGRIX VACC, SDV 50MCG/0.5ML0.5ML (10/BX)

Features
  • SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older
  • SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox)
  • SHINGRIX is supplied as 2 components: A single-dose vial of lyophilized gE antigen component (brown cap) and a single-dose vial of adjuvant suspension component (blue-green cap) (packaged without syringes or needles)
  • More …
Volume
1 Dose 10 Doses
  Log In to Order
or

Professionals Also Viewed


Product Specifications


McKesson #1081079
Manufacturer #58160082311
BrandShingrix®
ManufacturerGlaxo Smith Kline
Country of OriginUnknown
ApplicationShingles Vaccine
Container TypeSingle Dose Vial Kit
Dosage FormInjection
Generic Drug Code43989
Generic Drug NameZoster Vaccine Recombinant, Adjuvanted
NDC Number58160082311
Storage RequirementsRequires Refrigeration
Strength50 mcg / 0.5 mL
TypeIntramuscular
UNSPSC Code51201600
User50 Years of Age and Older
Volume10 Doses
Features
  • SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older
  • SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox)
  • SHINGRIX is supplied as 2 components: A single-dose vial of lyophilized gE antigen component (brown cap) and a single-dose vial of adjuvant suspension component (blue-green cap) (packaged without syringes or needles)
  • A single dose after reconstitution is 0.5 mL
  • Administer 2 doses (0.5 mL each) at 0 and 2 to 6 months
More Information